tm logo
Trademark Search
POWERING THE FUTURE OF IMMUNE MEDICINE.

View On IC.GC.CA

POWERING THE FUTURE OF IMMUNE MEDICINE.
ABANDONED SECTION 36

on 07 Nov 2023

Last Applicant/ Owned by

ADAPTIVE BIOTECHNOLOGIES CORP.

1551 Eastlake Avenue E, Suite 200Seattle WA 98102

US

Serial Number

2138248 filed on 09th Jul 2021

POWERING THE FUTURE OF IMMUNE MEDICINE.

Trademark usage description

providing medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of residual disease, and the analysis, evaluat Read More

Classification Information

Class [042]
Providing medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals for research purposes; development of new technology for others in the field of biotechnology; DNA analysis services for scientific research purposes; genetic testing for scientific research purposes; genome amplification; genotyping services for research or analysis purposes; laboratory research in the field of immune sequencing; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of immune sequencing; providing laboratory research services in the field of gene expression, namely, cancer biology; providing medical and scientific research information in the field of clinical trials; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development in the pharmaceutical and biotechnology fields; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; scientific research in the field of genetics and genetic engineering; DNA screening for scientific research purposes; medical research; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; custom design and development of chemical reagents and biochemical assays; development of new technology for others in the field of immunotherapy; laboratory research in the field of immunotherapy, oncology, hematology, auto-immune disorders, and infectious diseases; medical and scientific research in the field of immunotherapy; medical laboratory services.

Classification kind code

11

Class [044]
Providing medical diagnostic assays and diagnostic and prognostic testing for treatment purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of patient treatments, and to revise future treatments accordingly; medical services; consulting services in the field of medical diagnostic and prognostic testing; medical analysis services; medical analysis services for diagnostic and prognostic testing and treatment purposes; providing medical diagnostic and prognostic testing services.

Classification kind code

11

Mark Details

Serial Number

2138248

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 14
on 15th Aug 2023		Default Notice Sent
Submitted for opposition 22
on 27th Jan 2023		Search Recorded
Submitted for opposition 20
on 27th Jan 2023		Examiner's First Report
Submitted for opposition 223
on 27th Jan 2023		Total Provisional Refusal
Submitted for opposition 256
on 08th Aug 2022		Notification of Possible Opposition Sent
Submitted for opposition 257
on 07th Oct 2021		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 06th Oct 2021		Created
Submitted for opposition 31
on 06th Oct 2021		Formalized
Submitted for opposition 30
on 09th Jul 2021		Filed
Submitted for opposition 228
on 09th Jul 2021		International Registration